Has anyone experienced hsv2 on the face/lip/cheek?
I know everyone is different but does it look the same as hsv1?
Hey any help would be great. I’ve been losing my mind of this and I’ve been procrastinating on going to get tested because I’m scared of the results and also I have no insurance or anything to consult with a doctor.
so I got tested may of 2018 and I was positive for hsv1 which I feel like I may have gotten as a kid not sure, but since that test I’ve received unprotected oral sex twice and every since I’ve slowly been growing bumps on the meatus. I’m uncircumcised as well. Could this be herpes, warts, chlamydia? My girlfriend (I cheated on her and don’t know how to explain to her I might’ve caught something) has had a bit of blood discharge on her underwear in between periods. I work a lot and wear sort of tight clothing and I get smegma under the head as well. Smells bad too. Help!!! I’ve had this for months.
I’ve had HSV1g for 4 years and only ever had my first and only breakout. I’m super thankful for that. I still hate disclosing as it sets off alarms. Finally met a guy I really really like and disclosed last night to be clear about why I’ve been hesitant to be intimate.
We have for sure kissed and after telling he was in a panick about us having kissed. I’ve never ever had cold sores and have never passed it to anyone. Again in 4 years only my first and only genital HsV1 breakout. I’ve always been told kissing for me was fine....Can anyone help clarify? I’m resllt struggling as I like this guy a lot and hoping he can look past it.
First of let me tell you the intention and why this can be a great project, good investment and eventually something we could all benefit from.
A unique way of effort for funding our mutual problem with the ETH ERC20 Token.
Labcash is my idea born by our mutual friend HSV.
Just by looking at this forum I have noticed how much people complain about HSV funding (justified reason) and the institutions ignoring us at every possible step of the way.
When I need a doctor I never use public health because it would take me 6 months to get in line, instead I go to a private doctor and get all done in 30 minutes.
The same principle applies when we want something to be done such as HSV research, we can order a private laboratory that would conduct studies on our behalf without restrictions.
Raising funds to start/continue and eventually complete a study is difficult especially when we know that repeated funding is necessary.
The solution is offered by the blockchain and crypto assets.
You may or may not be familiar with cryptocurrency however it has massive advantages such as competing against other cryptocurrencies on an exchange that directly benefits us as the value of the Token goes up gives us more investment power and not only that but we are able to make our own acyclovir product that will not feed the big pharma but our chosen investment lab and our token.
The possible side effect is the volatility in the crypto market that would make the token more valuable than the initial purchase price making some extra profit for token holders (not the goal but a good one).
1. Tokens sold to HSV sufferers.
2. Signing the contract with the laboratory for drug development (Pivot park in the Netherlands is the chosen default).
3. Research begins.
4. Production and packaging of acyclovir on the lowest possible price for packaging, shipping, and reinvestment to the blockchain.
5. Sales and returns in the blockchain for future research.
6. Eventual new drugs will be discovered thanks to passive funding/market exploitation.
Token name: Labcash
If you are interested in participating in the project visit www.community-labs.eu or send an email on firstname.lastname@example.org for future clarification.
If you are interested in buying the Token you will need a chrome extension called Metamask (all explained on the website) then you can buy the Token on this link:
As always doing something is always better than nothing :)
If you have any questions ask here or send it to the info email.
If you’ve followed this ASP2151 thread, you may know that I’ve been taking amenamevir (Amenalief) for about two months. In these two months, I have had absolutely no symptoms and no side effects to speak of. I’m ordering blood work soon to confirm that there are no major changes in important biomarkers (kidney, liver, heart, etc.) but I haven’t experienced any side effects that I could observe myself (headaches, diarrhea, insomnia, mood changes etc.) However, there is no data about the effectiveness of valacyclovir + amenamevir on reducing HSV recurrences. Two months of being on this combination is not enough to tell how well it works.
As a community, what we need is a functional cure. There’s a lot of excitement surrounding pritelivir in this regard. Pritelivir, like amenamevir, is a new drug inhibits the HSV helicase-primase complex. This is a different target than valacyclovir, which is why combining the two has major potential to be a functional cure. If you’ve read Josh Bloom’s article on the possibility of using pritelivir and valacyclovir together as a sort of HIV-like cocktail, then you’ve probably realized this combo is the only way in the foreseeable future that we will have a functional cure.
Here’s the reality of the situation.
There will not be a vaccine in the foreseeable future (barring a miracle that allows GEN-003 to continue. I wouldn’t count on that).
There will not be a CRISPR treatment in the foreseeable future.
The only HSV drug that is going through clinical trials (past pre-clinical) is pritelivir. That means that aside from amenamevir and pritelivir, there will not be any new drugs on the market for at least ten years.
You are not getting much help from the pharmaceutical companies. It’s the truth. Many people here are already aware of this. Look at the HSV pipeline. Other than the helicase-primase inhibitors, there is little to no progress being made, and the failure rate is incredibly high.
If you want, you can wait ten years hoping that the pharmaceutical companies come out with something. The only alternative is to conduct our own trials and gather some data.
There are plenty of drugs/supplements with studies that have some evidence to support their use in preventing HSV recurrences, but there’s not much consensus on whether they actually improve anything. A lot of them have been tested in animals, but not in humans for the purpose of reducing HSV recurrences. Others have been tested in early-stage trials with very small sample sizes and don’t achieve statistical significance, even if the results are promising:
Aspirin & other COX-2 inhibitors Another link
and plenty more.
Some people have also speculated that diet changes (ketogenic diet, intermittent fasting, etc.) also lead to dramatic improvement in symptoms. There is plenty of reason to be skeptical about these claims, especially when they only come from a small number of people. The sample size simply isn’t large enough.
And, of course, there’s a new drug that we know to be a strong inhibitor of HSV replication: amenamevir. Just as famciclovir has the same effect on HSV as valacyclovir, amenamevir has the same effect on HSV as pritelivir. And, as some of you know, amenamevir is approved in Japan and can be purchased online.
In many cases, valacyclovir by itself is not enough to stop all symptoms/recurrences. Additionally, valacyclovir doesn’t reduce shedding as much as it should. But research has found a strong correlation between number of recurrences and shedding. If we get recurrences down to zero, chances are that shedding is close to zero. At the very least, it means with very high probability that shedding has been significantly reduced.
Clearly, to achieve a functional cure, valacyclovir is not enough. But when combined it with other drugs/supplements/diets, it could achieve a functional cure or at least eliminate all outbreaks (which all but guarantees a very low level of shedding). Hypothetically, valacyclovir might reduce the average number of outbreaks per year from 3 to 1. Taking amenamevir in combination with valacyclovir might reduce that number to .5. Taking glutamine with amenamevir and valacyclovir might reduce that number to .2 (this is just a hypothetical example). Many of these combos may have a synergistic effect, meaning that using both drugs together would have a stronger effect than the effects of each individual drug combined. And how will we actually figure this out? By doing our own clinical trial.
We need a significant amount of participants. A trial will have at least sixty participants (more is better, but sixty is doable) for a three month period. I’ve created to gather some basic information about people (nothing personal or potentially identifying. Just things like age, time of diagnosis, frequency of outbreaks in the past year, whether or not they currently take medication. This data will help group the study participants properly) and a spreadsheet for a trial participant to record when they get an outbreak and to briefly describe the symptoms. The group will be split in half, with thirty participants taking only valacyclovir and the other half taking valacyclovir along with whatever we want to study in combination with valacyclovir. Other standard study procedures such as randomization of the groups will be incorporated into the trial. All the participants have to do is take the pills and record any outbreaks they have, briefly describe the symptoms, and write down when they are fully healed from the outbreak.
At the end of the trial, we will have three months of data for sixty participants. That’s ninety months, or seven and a half years of data, in each group. If the valacyclovir group had a total of ten outbreaks, then the average number of recurrences per year would be about 1.3. If the combo group had a total of five outbreaks, then the average number of recurrences would be about .7. Finally, we test to see if the combo led to a statistically significant reduction in outbreaks compared to the valacyclovir only group. The larger the study group, the more statistically significant the findings will be, which is why a large number of participants is crucial.
Finally, we finalize the trial by performing any other important data analysis. For example, we could see if there is any correlation between age and efficacy of the treatment. We generate graphs and charts and write a brief “paper” presenting the findings.
The only one of these trials that would actually “cost” a lot of money would be an amenamevir trial (amenamevir, although available, is pretty expensive). However, if enough people are willing to participate in one, we could get data on what looks to be the most effective treatment that is currently available.
A trial to assess the effect of any other drug, supplement, or diet would practically cost nothing. Aspirin, glutamine, lactoferrin, and propranolol are widely available and inexpensive, as are many of the other possible treatments, and these trials assume that participants are already taking valacyclovir whether it is covered by their insurance or not. And these trials do not require a major time commitment. The participant will have to verify at the beginning of the trial that they have the study drugs/supplements in their possession (just send a picture and blur out any personal info if there’s a prescription bottle). They take one or two pills a day and record any recurrences. In trials with potential side effects (e.g. lithium), the participant records any side effects. At the end of the study, the participant sends the spreadsheet over. That’s it.
These studies and data may not be as high quality as that of many clinical trials, but they are certainly useful. By obtaining this data, we give ourselves the ability to treat this disease better than ever before. Instead of shooting fish in a barrel and hoping some supplement works because one person on the internet said it did or because a supplement had an effect in an animal study, you’ll be able to rely on real data from humans. Not only that, but that data will be on a combination of valacyclovir and whatever else is being taken, which there are very few if any human studies on.
TL;DR: Doing crowdsourced trials on different combinations of valacyclovir and other compounds, we can see which compounds are effective for improving HSV. You can participate, and it is minimally time-consuming and costs next to nothing (unless you want to do an amenamevir trial). Participating will help us gather data to improve our conditions dramatically.
If you’re interested in participating, please fill out this form: https://goo.gl/forms/Q50PKY8I11tVMsLh2
I am not interested in anyone’s personal data. These studies are to remain anonymous and I will never ask for or attempt to collect any personal data. The only reason I ask for age in the form is because is a potential variable to account for in data analysis. You do not need to provide your age if you don't want to.
All communications should be done through this website’s messaging system or using an email that does not link to your identity. You can reach me at honeycombstudy at gmail.com or message me on this site.
Any questions and/or skepticism are more than welcome.
Finally, if anyone would like to contribute to this project please contact me! Let’s start taking action.
- 4 replies
- 23 views
- 2 replies
- 17 views
By Marie053, in Just signed up? Say hello here!
- 9 replies
- 64 views
- 1 reply
- 24 views
By ThoughtsBecomeThings, in Nature has a Remedy
- 8 replies
- 40 views